Anti-vascular endothelial growth factor monoclonals in non-small cell lung cancer
AB Sandler, DH Johnson, RS Herbst - Clinical cancer research, 2004 - AACR
There is an urgent need for new therapies to treat non-small cell lung cancer (NSCLC)
because current chemotherapy regimens are of limited effectiveness. The role of vascular …
because current chemotherapy regimens are of limited effectiveness. The role of vascular …
Anti-vascular endothelial growth factor monoclonals in non-small cell lung cancer.
AB Sandler, DH Johnson, RS Herbst - Clinical Cancer Research: an …, 2004 - europepmc.org
There is an urgent need for new therapies to treat non-small cell lung cancer (NSCLC)
because current chemotherapy regimens are of limited effectiveness. The role of vascular …
because current chemotherapy regimens are of limited effectiveness. The role of vascular …
Anti-vascular endothelial growth factor monoclonals in non-small cell lung cancer
AB Sandler, DH Johnson… - … cancer research: an …, 2004 - pubmed.ncbi.nlm.nih.gov
There is an urgent need for new therapies to treat non-small cell lung cancer (NSCLC)
because current chemotherapy regimens are of limited effectiveness. The role of vascular …
because current chemotherapy regimens are of limited effectiveness. The role of vascular …
Anti-vascular endothelial growth factor monoclonals in non-small cell lung cancer
AB Sandler, DH Johnson… - Clinical Cancer …, 2004 - utsouthwestern.elsevierpure.com
There is an urgent need for new therapies to treat non-small cell lung cancer (NSCLC)
because current chemotherapy regimens are of limited effectiveness. The role of vascular …
because current chemotherapy regimens are of limited effectiveness. The role of vascular …
Anti-Vascular Endothelial Growth Factor Monoclonals in Non-Small Cell Lung Cancer
AB Sandler, DH Johnson, RS Herbst - Clinical Cancer Research, 2004 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> There is an urgent need for new therapies to
treat non-small cell lung cancer (NSCLC) because current chemotherapy regimens are of …
treat non-small cell lung cancer (NSCLC) because current chemotherapy regimens are of …
[引用][C] Anti-vascular endothelial growth factor monoclonals in non-small cell lung cancer
AB SANDLER, DH JOHNSON… - Clinical cancer …, 2004 - pascal-francis.inist.fr
Anti-vascular endothelial growth factor monoclonals in non-small cell lung cancer CNRS
Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …
Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …